Townsquare Capital LLC lowered its holdings in shares of Walgreens Boots Alliance, Inc. ( NASDAQ:WBA – Free Report ) by 4.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission.
The institutional investor owned 43,108 shares of the pharmacy operator’s stock after selling 1,909 shares during the quarter. Townsquare Capital LLC’s holdings in Walgreens Boots Alliance were worth $402,000 at the end of the most recent reporting period. Other institutional investors also recently bought and sold shares of the company.
Vanguard Group Inc. boosted its stake in Walgreens Boots Alliance by 2.7% during the 4th quarter.
Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock worth $805,506,000 after purchasing an additional 2,279,495 shares during the last quarter. Invesco Ltd.
boosted its position in Walgreens Boots Alliance by 8.8% during the fourth quarter. Invesco Ltd.
now owns 32,572,567 shares of the pharmacy operator’s stock worth $303,902,000 after acquiring an additional 2,631,332 shares during the last quarter. Geode Capital Management LLC grew its stake in Walgreens Boots Alliance by 5.2% during the 4th quarter.
Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator’s stock valued at $194,082,000 after acquiring an additional 1,020,587 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Walgreens Boots Alliance by 19.
9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after acquiring an additional 2,185,950 shares during the last quarter.
Finally, Norges Bank purchased a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $58,241,000. 58.59% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In WBA has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their price target for the company from $11.00 to $9.
00 in a report on Friday, February 28th. Truist Financial reduced their price target on Walgreens Boots Alliance from $13.00 to $12.
00 and set a “hold” rating on the stock in a report on Friday, January 31st. Bank of America upped their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.
50 and gave the company an “underperform” rating in a report on Monday, January 13th. Royal Bank of Canada lifted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.
00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Finally, Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock.
According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $10.59. Walgreens Boots Alliance Stock Up 0.
8 % Walgreens Boots Alliance stock opened at $10.89 on Monday. The company has a market capitalization of $9.
42 billion, a PE ratio of -1.06, a price-to-earnings-growth ratio of 1.31 and a beta of 0.
67. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.
30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc.
has a fifty-two week low of $8.08 and a fifty-two week high of $18.83.
The firm has a 50 day moving average price of $10.85 and a 200 day moving average price of $10.15.
Walgreens Boots Alliance ( NASDAQ:WBA – Get Free Report ) last issued its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.
53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.
61% and a negative net margin of 5.87%. The business had revenue of $38.
59 billion during the quarter, compared to analysts’ expectations of $37.90 billion. During the same period in the previous year, the firm posted $1.
20 earnings per share. The company’s revenue was up 4.1% on a year-over-year basis.
Research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Walgreens Boots Alliance Profile ( Free Report ) Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S.
Retail Pharmacy, International, and U.S. Healthcare.
The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Stories Five stocks we like better than Walgreens Boots Alliance The 3 Best Fintech Stocks to Buy Now With a 60%+ Upside, There’s Plenty to Love About Lovesac What is the Dow Jones Industrial Average (DJIA)? J.B. Hunt Transport Overcorrects Into a Buying Opportunity How Investors Can Find the Best Cheap Dividend Stocks AppLovin: Can Record Profits Overcome Market Skepticism? Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. ( NASDAQ:WBA – Free Report ). Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.
com's FREE daily email newsletter ..
Business
Townsquare Capital LLC Cuts Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Townsquare Capital LLC lowered its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 4.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 43,108 shares of the pharmacy operator’s stock after selling 1,909 shares during the quarter. Townsquare Capital [...]